Chronic Enteroviral Infection Modifies Broadly Pancreatic Cellular Functions
Lietzen et al. iScience. 19:340-357, 2019.
The goal of the new study by the research groups of Academy Professor at Turku Bioscience Centre Riitta Lahesmaa and Professor at Tampere University Heikki Hyöty was to understand the mechanisms that control the development of chronic enteroviral infection in the pancreas. The study also aimed at creating a comprehensive picture on the alterations caused by enteroviral infection that could possibly have adverse health effects.
In the study, cutting-edge proteomic methods were utilised to measure how the infection influences the expression and secretion of thousands of different proteins in the cellular models of chronic pancreatic enteroviral infection.
Having persisted for almost a year, the chronic enteroviral infections modified the cellular expression of numerous proteins that are key to cellular functions, such as proteins regulating energy metabolism. The infections also caused alterations in the secretion of several proteins.
– For example, the levels of proteins in the regulated secretory pathway participating in the secretion of hormones such as insulin in the beta-cells decreased with the chronic infection. The infections also clearly affected the levels of other proteins that are involved in the function and survival of beta-cells, says Dr Niina Lietzén from the Turku Bioscience Centre.
– Interestingly, chronic infections that had been developed by using two different virus strains triggered partly very different responses. For example, major differences in the activation of immune responses were discovered between these two models. This indicates that the viruses have different kinds of abilities to manipulate the cellular defence systems, adds Hyöty.
Published in the iScience journal, the study revealed several mechanisms through which chronic enteroviral infections can impact pancreatic functioning and possibly the development of type 1 diabetes.
The report is part of the ongoing doctoral studies of Doctoral Candidates Anni Honkimaa from Tampere University and Karoliina Hirvonen from the University of Turku.
Original publication:
Lietzén, N., Hirvonen, K., Honkimaa, A., Buchacher, T., Laiho, J.E., Oikarinen, S., Mazur, M.A., Flodström-Tullberg, M., Dufour, E., Sioofy-Khojine, A.-B., Hyöty, H., Lahesmaa, R. Coxsackievirus B persistence modifies the proteome and the secretome of pancreatic ductal cells. ISCIENCE (2019).
More information:
Riitta Lahesmaa, Academy Professor, Turku Bioscience Centre, +358 40 718 4813, rilahes@utu.fi
Heikki Hyöty, Professor, Tampere University, +358 50 516 8480, heikki.hyoty@tuni.fi
Recent Posts
- Early-career researchers invited to BioCity Pre-Symposium on 26 August. Registration is now open!Doctoral researchers at BioCity Turku are organising a pre-symposium on 26 August 2026, offering early-career Read moreApril 30, 2026
- 35th BioCity Symposium is arranged 27–28 August 2026. Registration is now open!This year, BioCity Symposium is arranged on-site in Mauno Koivisto Centre, BioCity in 27–28 August Read moreApril 14, 2026
- Turku Protein Core Opens Two New PositionsTurku Protein Core (TuProtCore) is seeking to fill two roles: a Project Specialist in Service Read moreApril 7, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026